Extraterrestrial ventures are no longer limited to deep-pocketed tycoons.
Patients don’t need “stem cell tourism” anymore—ineffective and potentially dangerous interventions abound at home.
Same-day grocery delivery is a notoriously difficult business, but Instacart believes it’s found a way to make money.
The National Cancer Institute hopes a new data-sharing agreement with Foundation Medicine is the first of many.
ADI hopes its pioneering agricultural experiment will yield juicier, tastier tomatoes.
People with red-green color-blindness can suddenly discriminate between colors they couldn’t see before.
Decision making is influenced by the complexity of the situation, the skill of the decision maker, and the time pressure. But one of these is much more important than the others, a new study reveals.
Another chance to catch the most interesting, and important, articles from the previous week on MIT Technology Review.
Stroke survivor Jim Gass wanted to be healed with stem cells. Instead, they ended up hurting him.
Inovio’s DNA-based vaccine for Zika virus will be the first of several vaccines expected to undergo tests in humans this year.